Average Co-Inventor Count = 5.55
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Agios Pharmaceuticals, Inc. (29 from 96 patents)
2. Takeda Pharmaceutical Company Limited (8 from 1,177 patents)
3. Servier Pharmaceuticals LLC (7 from 21 patents)
4. Janssen Pharmaceutica Nv (4 from 2,076 patents)
5. 3-dimensional Pharmaceuticals, Inc. (3 from 76 patents)
6. Shire Human Genetic Therapies, Inc. (1 from 86 patents)
7. Les Laboratoires Servier (290 patents)
52 patents:
1. 12441724 - Inhibitors of plasma kallikrein and uses thereof
2. 12433895 - Therapeutically active compounds and their methods of use
3. 12221441 - Plasma kallikrein inhibitors and uses thereof
4. 12065448 - Heteroaryl plasma kallikrein inhibitors
5. RE49934 - Inhibitors of cellular metabolic processes
6. 11905285 - Inhibitors of plasma kallikrein and uses thereof
7. 11844758 - Therapeutically active compounds and their methods of use
8. 11787796 - Plasma Kallikrein inhibitors and uses thereof
9. 11667673 - Therapeutically active compounds and their methods of use
10. 11524960 - Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer
11. 11505538 - Therapeutically active compounds and their methods of use
12. 11370803 - Heteroaryl plasma kallikrein inhibitors
13. 11352356 - Inhibitors of plasma kallikrein and uses thereof
14. 11325914 - Inhibitors of cellular metabolic processes
15. 11168083 - Inhibitors of Plasma Kallikrein and uses thereof